Ontrak, Inc. Expected to Post FY2028 Earnings of $0.12 Per Share (NASDAQ:OTRK)

Ontrak, Inc. (NASDAQ:OTRK) – Stock analysts at Roth Capital issued their FY2028 earnings per share estimates for Ontrak in a note issued to investors on Tuesday, April 16th. Roth Capital analyst J. Aschoff expects that the company will earn $0.12 per share for the year. The consensus estimate for Ontrak’s current full-year earnings is ($0.34) per share.

Ontrak Price Performance

Ontrak stock opened at $0.28 on Friday. Ontrak has a fifty-two week low of $0.14 and a fifty-two week high of $4.08. The stock’s fifty day moving average is $0.28 and its two-hundred day moving average is $0.46.

Institutional Trading of Ontrak

Large investors have recently made changes to their positions in the stock. Two Sigma Investments LP boosted its stake in shares of Ontrak by 119.9% during the first quarter. Two Sigma Investments LP now owns 51,600 shares of the company’s stock valued at $27,000 after acquiring an additional 28,131 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Ontrak during the third quarter valued at $34,000. Renaissance Technologies LLC acquired a new stake in shares of Ontrak during the second quarter valued at $35,000. Charles Schwab Investment Management Inc. boosted its stake in shares of Ontrak by 51.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 29,007 shares of the company’s stock valued at $66,000 after acquiring an additional 9,895 shares during the last quarter. Finally, XTX Topco Ltd boosted its stake in shares of Ontrak by 273.2% during the first quarter. XTX Topco Ltd now owns 50,431 shares of the company’s stock valued at $114,000 after acquiring an additional 36,918 shares during the last quarter. Institutional investors and hedge funds own 12.95% of the company’s stock.

Ontrak Company Profile

Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.